We have shown that Alox5 is a critical regulator of leukemia stem cells (LSCs) in a BCR-ABLinduced chronic myeloid leukemia (CML) mouse model, and we hypothesize that the Alox5 pathway represents a major molecular network that regulates LSC function. Therefore, we sought to further dissect this pathway by comparing the gene expression profiles of wild type and
INTRODUCTION
Cancer stem cells (CSCs) are believed to be promising targets with the potential to offer curative therapies for some types of cancer, especially leukemias. A number of genes and their pathways, including Wnt/β-Catenin 1, 2 , Hedgehog 3 , Notch 4 , Bim-1 5 , p53 4 , p16 6 and p19 7 , Pten 8 , PML 9 , PP2A 10 , Alox5
11
, TGF-beta/FOXO 12 and Musashi 13 , have been found to promote or inhibit CSC proliferation. Some of these genes and pathways also play similar roles in regulating the function of normal stem cells 1, 6, 14 . There is a need to identify CSC-specific genes for developing anti-stem cell strategies. Chronic myeloid leukemia (CML) is a stem cell-derived hematologic malignancy and serves as a good disease model for the study of CSC behavior and function. We have previously identified BCR-ABL-expressing Lin -Sca-1 + c-Kit + cells as leukemia stem cells (LSCs) in CML mice 15 . We have demonstrated the critical role of the Alox5 gene in functional regulation of LSCs 11 . We believe that the Alox5 pathway represents a major pathway that regulates the function of LSCs, and it will be important to identify other genes that interact with Alox5.
In theory, genes regulating LSC function can be grouped in two categories: those that enhance or promote LSC function or those that suppress and/or negatively regulate LSC function.
Genetic deletions and/or mutations in the latter group are likely to favor leukemogenesis and a few genes in this category have been identified in LSCs. For example, Pten is down-regulated by BCR-ABL in LSCs. Pten deletion accelerates CML development and delays the disease upon overexpression 16 . p53 is also down-regulated by BCR-ABL and loss of p53 accelerates CML development 17, 18 . In this study, we identified that macrophage scavenger receptor (Msr1)
suppresses BCR-ABL-expressing LSCs and CML development. Msr1 is a member of scavenger Using Msr1 -/-mice, we show that Msr1 delays CML development and regulates the self-renewal and differentiation capacity of LSCs through PI3K-AKT-GSK-3β and β -Catenin pathways.
METHODS AND MATERIALS

Mice
C57BL/6, B6.SJL-Ptprca Pepcb/BoyJ, homozygous Alox5 knockout (Alox5 -/-) mice and homozygous Msr1 knockout (Msr1 -/-) mice in a C57BL/6 background were obtained from The Jackson Laboratory (Bar Harbor, Maine). Mice were maintained in a temperature-and humiditycontrolled environment and given unrestricted access to 6% chow diet and acidified water.
DNA Microarray
Bone marrow cells from C57BL/6 (B6) or Alox5 -/-mice pre-treated with 5-fluorouracil (5-FU)
were transduced with BCR-ABL, followed by transplantation into B6 recipient mice (30 recipient mice for each group). 14 days later, bone marrow cells were isolated and subsequently sorted by FACS for LSCs (GFP + Lin -c-Kit + Sca-1 + ). Total RNA was isolated from these BCR-ABL-expressing LSCs or from the GFP + Lin -c-Kit + Sca-1 + cells that only expressed GFP, and DNA microarray analysis was carried out using the Affymetrix chips. All microarray data related to this Blood paper have been deposited into the GEO public database, with accession numbers GSE10912 and GSE29347.
DNA constructs
Human 
Cell lines
Human K562 myeloid leukemia cell line was grown in RPMI 1640 medium containing 10% FCS. To generate the Msr1-expressing K562 cell lines, K562 cells were transduced with the pMSCV-Msr1-GFP retrovirus, and the Msr1-expressing cells were sorted for GFP by fluorescence-activated cell sorter (FACS). K562 cells transduced with the pMSCV-GFP retrovirus were used as a control.
Flow cytometry
Hematopoietic cells were collected from the bone marrow and peripheral blood of the normal and diseased mice. Erythrocytes were lysed in NH 4 Cl red blood cell lysis buffer (pH 7.4). The cells were washed with PBS and stained with B220-PE for B cells, Gr-1-APC for neutrophils, Mac-1-PE for macrophages, CD3E-APC for T cells and Sca-1/c-Kit/CD34/CD135 (Flt3)/CD204
for HSCs. All of these antibodies were purchased from Ebioscience Inc and Serotec Inc. After staining, the cells were washed once with PBS and subjected to FACS analysis. 
Bone marrow transduction/transplantation
The retroviral vector MSCV-IRES-EGFP carrying the p210 BCR-ABL cDNA was used to make high-titer, helper-free, replication-defective ecotropic virus stock by transient transfection of 293T cells using the kat system as previously described 21, 22 . 6-to 10-week-old wild-type C57BL/6 mice (The Jackson Laboratory, Bar Harbor, Maine, and U.S.A) were used for leukemogenesis experiments. Induction of CML and B-ALL was as previously described y 
Western blot analysis and antibodies
Antibodies against c-ABL, β -actin, β -Catenin and MSR1 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA) and antibodies against p-Pten, Pten, p-PI3K, PI3K, p-AKT, AKT, p-GSK-3β and GSK-3β from Cell Signal Technology (Danvers, MA). Protein lysates were prepared by lysing cells in RIPA buffer and western blotting was carried out as described previously 24 .
In vitro culture of LSCs and drug treatment
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From Bone marrow cells isolated from CML mice were cultured in vitro in the presence of Stemspan SFEM (Stemcell Technologies, Vancouver, CA), stem cell factor, insulin-like growth factor-2, thrombopoietin, heparin, and α -fibroblast growth factor as described previously 25 . PMA (Sigma)
were dissolved in dimethyl sulfoxide (DMSO) to make stock solution at 10mM, and were then diluted in culture media to different concentrations for use.
Histology
The lungs from the placebo-or drug-treated mice were fixed in Bouin fixative (Fisher Scientific, Pittsburgh, PA) for 24 hours at room temperature, followed by an overnight rinse in water. 10-µm sections were stained with hematoxylin and eosin (H&E) and observed by a model DMRE compound microscope (Leica, Heidelberg, Germany). All sections were imaged with a 2. 
Statistics
Statistical analyses were performed by using Student t Test (*: p<0.05, **: p<0.01) (GraphPad Prism v5.01 software for Windows, GraphPad Software, San Diego, CA USA). 1C ). This down-regulation was rescued by the loss of Alox5 (Fig. 1D ). These results suggest that 
RESULTS
Loss of Msr1 accelerates CML development
Msr1 over-expression delays CML development
To further test whetherMsr1 can inhibitCML development, we co-expressed BCR-ABL 
Msr1 deletion causes an increase in LSC function
CML is a stem cell-derived disease and the accelerated development of CML in absence of Msr1 ( Fig. 1 3F) .
Induction of Msr1 expression by PMA causes inhibition of human CML cells and LSCs
Next, we tested whether Msr1 inhibits human CML cells. Phorbol 12-myristate 13-acetate (PMA) induces differentiation of THP-1 cells, leading to a marked increase in the expression of MSR1 on the cell surface 26 . We found that the level of MSR1 was significantly increased in K562 cells treated with PMA for 48 hours (Fig. 4A) . We also noted that PMA significantly inhibited the proliferation of K562 cells (Fig. 4B) . The decreased proliferation of K562 cells was consistent with an increase in apoptosis (Fig. 4C) . We also tested whether PMA inhibits LSCs from CML in vitro under stem cell culture conditions. We cultured bone marrow cells from CML mice in the presence of imatinib (1 µM) or PMA (80 nM) for 3 days, and calculated the total number and percentage of LSCs that remained at the end of the culture
based on FACS analysis and total cell counts. We showed that PMA significantly inhibited LSCs in vitro (Fig. 4D) LSCs was reduced in a much lesser degree than the reduction of wild type LSCs by PMA (Fig.   4E ), indicating that the induction of Msr1 contributes to the inhibition of LSCs by PMA.
Msr1 deletion does not affect the function of normal HSCs
We further tested whether the loss of Msr1 affects the function of normal HSCs. (Fig. S3A) . The pMSCV-Msr1-GFP construct expressed MSR1 and GFP and the pMSCV-GFP construct expressed GFP in 293T cells (Fig. S3B ). K562 cells transduced with pMSCV-Msr1-GFP or pMSCV-GFP were sorted by FACS for GFP + cells and over-expression of MSR1 was confirmed by FACS ( Fig.S3C ) and Western blotting (Fig. 6D ). We found that over-expression of Msr1 inhibited the activation of the PI3K and AKT, reduced expression of β -catenin (Fig. 6D) , and suppressed proliferation of leukemia cells (Fig. 6E) . Together, these results suggest that Msr1 is a negative regulator between BCR-ABL-activated Alox5 and the PI3K-AKT-GSK-3β and β -catenin pathways (Fig.   6F ). 1 4 We also tested whether Msr1 affects BCR-ABL-induced acute lymphoblastic leukemia (ALL), which originates from committed lymphoid progenitors. Wild type or Msr1 -/-donor bone marrow cells were transduced by BCR-ABL-GFP retrovirus, followed by transplantation cells into lethally irradiated wild type recipient mice. Both groups of mice developed and died of ALL with similar disease latency and survival time (Fig. 7A) . FACS analysis of lymphoid leukemia cells showed that both groups of ALL mice had similar percentages of B220 + leukemia cells in peripheral blood of these mice ( Fig. 7B and C) although the mass of spleen in Msr1 -/-donor group was slightly more elevated than wild type group (Fig. 7D) . Together, these results showed that Msr1 did not affect the development of BCR-ABL induced ALL, and suggest that Msr1 is not required by ALL stem cells.
Msr1 does not affect BCR-ABL-induced lymphoid leukemia
DISCUSSION
In this study, we show that the reduction of LSCs in the absence of Alox5 is partially due For
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